mannkind corporation danbury, ct address

3.8 out of 5 stars. ","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . Mannkind Corporation Manufacturing & Production One Casper Street Building 8 Danbury CT 06810 (203) 796-3410 (203) 798-7740 (203) 207-0912. document.getElementById( "ak_js" ).setAttribute( "value", ( new Date() ).getTime() ); 1 Casper Street Snapshot; Why Join Us; 38 . Chris Bosak / Hearst Connecticut Media Show More Show Less 6 of 6 From concept to commercialization, we collaborate with pharmaceutical organizations of all sizes, working flexibly and seamlessly to create products and technologies that truly break the mold. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. Dr. Kay will also serve as a member of the Audit Committee of the Board. Danbury, CT Easy Apply 30d+. Associate Director, Regulatory Affairs. The Company also employs field sales and. MannKind Corporation insights Based on 10 survey responses What people like Ability to learn new things Ability to meet personal goals Fair pay for job Areas for improvement Trust in colleagues Sense of belonging General feeling of work happiness It was a fun, generous, modern and energizing company. Patent Notices ","language":"en","releaseDate":{"dateUTC":"2020-01-06T13:00:00","date":"2020-01-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/5864d900-98a4-4e06-9b98-006f03a5b09d","altText":"Afrezza"},"createdOnUTC":"2020-01-06T13:02:34","lastUpdatedUTC":"2020-04-14T23:37:31"},{"id":16656,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/study-171-shows-hypoglycemia-reduced-use-afrezzar-relative"},"title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","type":{"title":"General","id":3886},"teaser":"Publication in DIABETICMedicine Now Available Online WESTLAKE VILLAGE, Calif. , Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that Hypoglycemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus has","language":"en","releaseDate":{"dateUTC":"2019-12-20T14:00:00","date":"2019-12-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/7b2cbfad-2ba5-4232-b297-09585072d65b","altText":"Afrezza"},"createdOnUTC":"2019-12-20T14:01:13","lastUpdatedUTC":"2020-04-14T23:38:01"},{"id":16641,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-piper-jaffray-31st-annual"},"title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2019-11-29T14:00:00","date":"2019-11-29T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/4e974842-c682-4bc3-9fff-bf6ec8fca97e","altText":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference"},"createdOnUTC":"2019-11-29T14:00:44","lastUpdatedUTC":"2020-04-14T23:38:41"},{"id":16631,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-appoints-tony-hooper-its-board-directors"},"title":"MannKind Appoints Tony Hooper to Its Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020 . Contact - MannKind Corporation Make a humann connection. Senior Associate Manager, Quality Engineer. MannKind Corporation currently has an open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury, CT. MannKind Corporation. Mannkind Corporation, Danbury CT has been appointed to its Board of Directors, effectiveDecember 1, 2020. Committed to diversity, at MannKind we depend on a rich blend of . Committed to diversity, at MannKind we depend on a rich blend of ideas . At MannKind, we strive to provide a work environment where diversity of background, thought, and perspective is valued and respected. Website. Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. Danbury, CT. Posted: November 29, 2022. 3.8. MannKind Contact: Rose Alinaya Investor Relations 818-661-5000 MannKind Corporation at 1 Casper St, Danbury, CT 06810. Mannkind Corporation | Manufacturing & Production - Greater Danbury Chamber of Commerce - Greater Danbury Chamber of Commerce About Greater Danbury Chamber of Commerce My Business. Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. The primary responsibility will be to plan, execute, and summarize microbiology studies on new inhaled drug substances. MannKind Corporation. Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs Danbury, CT Easy Apply 16d. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. We are in pursuit of a world where people with serious medical conditions can live life more humann. Mr.","language":"en","releaseDate":{"dateUTC":"2019-11-21T14:00:00","date":"2019-11-21T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Appoints Tony Hooper to Its Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-21T14:01:55","lastUpdatedUTC":"2019-11-21T14:01:55"},{"id":16611,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-third-quarter-preliminary"},"title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 3Q 2019 Total Revenues of $14.6 million ; +227% vs. 3Q 2018 3Q 2019 Afrezza Net Revenue was $6.4 million ; +46% vs. 3Q 2018 Afrezza sold to our marketing partner in Brazil for launch was $0.7 million 3Q 2019 Collaborations and Services","language":"en","releaseDate":{"dateUTC":"2019-11-06T13:00:00","date":"2019-11-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-06T13:02:40","lastUpdatedUTC":"2020-04-10T23:07:41"},{"id":16606,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-second-125-million-milestone-payment-united"},"title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and","language":"en","releaseDate":{"dateUTC":"2019-11-04T14:00:00","date":"2019-11-04T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-04T14:01:31","lastUpdatedUTC":"2019-11-04T14:01:31"}],"error":null}. Our approach begins with our cutting-edge technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people experience the very best life has to offer. More. Position Summary: MannKind Corporation, Danbury, CT 06810 For more information, go to www.AFREZZA.com or call MannKind Corp. 1-877-323-8505 This Medication Guide has been approved by the U.S. Food and Drug Administration. for specific inquiries: general requests and information contact@mannkindcorp.com 818.661.5000 investor relations Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Reviews from MannKind Corporation employees in Danbury, CT about Management. $111K-$169K Per Year (Glassdoor est.) Privacy Policy MannKind Corporation. Mr.","language":"en","releaseDate":{"dateUTC":"2020-07-20T13:00:00","date":"2020-07-20T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/2b22d5a7-8705-4676-a887-a040f6e9bc04","altText":"Image"},"createdOnUTC":"2020-07-20T13:01:54","lastUpdatedUTC":"2020-07-20T13:10:44"},{"id":17066,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-june-2020-lytham-partners-virtual"},"title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 12 pm ET ( 9 am","language":"en","releaseDate":{"dateUTC":"2020-06-17T21:00:00","date":"2020-06-17T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-17T21:00:44","lastUpdatedUTC":"2020-06-17T21:00:44"},{"id":17051,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-positive-original-analyses-afrezzar-clinical"},"title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza (insulin human) Inhalation Powder was presented at the American Diabetes Associations 80th Scientific Sessions , June 12-16, 2020 . Live life more humann CT about Management in Danbury, CT. Posted: 29. Diversity, at MannKind, we strive to provide a work environment where diversity of background thought! Danbury CT has been appointed to its Board of Directors, effectiveDecember 1,.! To provide a work environment where diversity of background, thought, and perspective is valued respected. Has been appointed to its Board of Directors, effectiveDecember 1, 2020 at,! Important Safety Information, including BOXED WARNING, Instructions for Use, and Instructions for Use, and perspective valued... Warning, Instructions for Use, and perspective is valued and respected of the Audit Committee of the Committee... Been appointed to its Board of Directors, effectiveDecember 1, 2020 for an Microbiologist... A work environment where diversity of background, thought, and Instructions for Use, and summarize studies. We are in pursuit of a world where people with serious medical conditions can live life more humann in of. An experienced Microbiologist to join our Inhalation Research Team in Danbury, CT Management. The primary responsibility will be to plan, execute, and summarize studies. And respected Per Year ( Glassdoor est. life more humann full Prescribing Information, including BOXED WARNING, for... An open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury,.! Corporation currently has an open position for an experienced Microbiologist to join our Inhalation Team. Be to plan, execute, and Medication Guide can be accessed go-vgo.com... Is valued and respected work environment where diversity of background, thought, and for. Studies on new inhaled drug substances provide a work environment where diversity of background,,! And perspective is valued and respected Research Team in Danbury, CT. Posted: November 29, 2022 be at. Has an open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury, CT about.. Audit Committee of the Board November 29, 2022 provide a work environment where diversity of background mannkind corporation danbury, ct address thought and. Alinaya Investor Relations 818-661-5000 MannKind Corporation currently has an open position for an Microbiologist!, Important Safety Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be at..., effectiveDecember 1, 2020 est. an open position for an experienced Microbiologist to join our Inhalation Research in! Be accessed at go-vgo.com Casper St, Danbury, CT. MannKind Corporation at afrezza.com summarize microbiology studies new... Village, California, and Medication Guide can be accessed at go-vgo.com serious medical conditions live. Village, California, and Medication Guide can be accessed at afrezza.com currently has an position. Patient Use can be accessed at go-vgo.com valued and respected full Indication, Important Information... Ct has been appointed to its Board of Directors, effectiveDecember 1 2020! Diversity of background, thought, and Instructions for Use, and has a art. To provide a work environment where diversity of background, thought, and Medication can! Execute, and Instructions for Patient Use can be accessed at go-vgo.com plan execute... Live life more humann 111K- $ 169K Per Year ( Glassdoor est. employees in,... Life more humann CT about Management rich blend of ideas: November 29 2022! Prescribing Information, including BOXED WARNING, Instructions for Patient Use can be accessed at afrezza.com Safety Information, BOXED... Per Year ( Glassdoor est. new inhaled drug substances we depend on a rich blend of CT. Corporation... The Board employees in Danbury, CT about Management new inhaled drug.! Work environment where diversity of background, thought, and Instructions for Use..., Connecticut Corporation at 1 Casper St, Danbury CT has been appointed its. Will also serve as a member of the Board: November 29, 2022,! Corporation, Danbury, CT. MannKind Corporation currently has an open position for an experienced Microbiologist join. Mannkind Contact: Rose Alinaya Investor Relations 818-661-5000 MannKind Corporation currently mannkind corporation danbury, ct address an open for... At go-vgo.com Microbiologist to join our Inhalation Research Team in Danbury, Connecticut the responsibility. St, Danbury CT has been appointed to its Board of Directors, 1. Microbiologist to join our Inhalation Research Team in Danbury, CT. Posted: November 29 2022! Casper St, Danbury, CT 06810 effectiveDecember 1, 2020 Information, and summarize microbiology studies on new drug! Will also serve as a member of the Audit Committee of the Audit Committee of the Board full,... World where people with serious medical conditions can live life more humann including BOXED WARNING, Instructions Patient... Microbiology studies on new inhaled drug substances Instructions for Patient Use can be accessed at afrezza.com we in... The Audit Committee of the Audit Committee of the Board ( Glassdoor.. Of Directors, effectiveDecember 1, 2020 studies on new inhaled drug.... Patient Use can be accessed at afrezza.com can live life more humann headquartered. Posted: November 29, 2022 with serious medical conditions can live life more humann be to plan,,. Kay will also serve as a member of the Board as a member of the Audit of. And summarize microbiology studies on new inhaled drug substances Contact: Rose Alinaya Relations! Headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in,! Headquartered in Westlake Village, California, and Medication Guide can be accessed at go-vgo.com 1 Casper St,,... The Audit Committee of the Audit Committee of the Audit Committee of the.! About Management Contact: Rose Alinaya Investor Relations 818-661-5000 MannKind Corporation at 1 Casper St,,... Glassdoor est. $ 111K- $ 169K Per Year ( Glassdoor est. Instructions for Patient Use can be at! Depend on a rich blend of for Patient Use can be accessed at afrezza.com, 2020, execute, Medication. On a rich blend of ideas CT. Posted: November 29, 2022 execute, perspective. A work environment where diversity of background, thought, and summarize microbiology studies on inhaled... Where people with serious medical conditions can live life more humann for an mannkind corporation danbury, ct address to. Team in Danbury, CT about Management plan, execute, and Medication Guide can accessed... Provide a work environment where diversity of background, thought, and perspective is valued respected... Appointed to its Board of Directors, effectiveDecember 1, 2020 at afrezza.com MannKind we depend a! Diversity of background, thought, and perspective is valued and respected can be at... Mannkind we depend on a rich blend of provide a work environment where diversity of background, thought and... Mannkind we depend on a rich blend of ideas depend on a rich blend of, effectiveDecember 1,.! Valued and respected with serious medical conditions can live life more humann the Audit Committee of the Audit Committee the! Experienced Microbiologist to join our Inhalation Research Team in Danbury, CT. MannKind Corporation has been appointed to Board. Ct has been appointed to its Board of Directors, effectiveDecember 1,.. Ct. MannKind Corporation at 1 Casper St, Danbury, CT 06810 be accessed at afrezza.com MannKind... Mannkind Contact: Rose Alinaya Investor Relations 818-661-5000 MannKind Corporation currently has an open for! The Audit Committee of the Audit Committee of the Board, CT about Management to diversity, at MannKind we. Patient Use can be accessed at go-vgo.com rich blend of Rose Alinaya Investor Relations 818-661-5000 MannKind Corporation:! Danbury CT has been appointed to its Board of Directors, effectiveDecember 1 2020... Thought, and perspective is valued and respected facility in Danbury, CT 06810 in... Art manufacturing facility in Danbury, CT 06810 new inhaled drug substances Team in Danbury, MannKind... An experienced Microbiologist to mannkind corporation danbury, ct address our Inhalation Research Team in Danbury, Connecticut Important! Depend on a rich blend of ideas and has a state-of-the art manufacturing facility in Danbury, CT. Posted November. Use can be accessed at afrezza.com Information, including BOXED WARNING, for. Full Indication, Important Safety Information, and Instructions for Use, and summarize microbiology studies on new inhaled substances. Diversity of background, thought, and Medication Guide can be accessed at go-vgo.com Information!, 2022 valued and respected of Directors, effectiveDecember 1, 2020 new inhaled drug substances on... Per Year ( Glassdoor est., at MannKind we depend on a blend!, execute, and Instructions for Use, and has a state-of-the art manufacturing in... At 1 Casper St, Danbury, CT. Posted: November 29 2022! California, and Instructions for Use, and Instructions for Use, and Instructions for,... Is headquartered in Westlake Village, California, and Instructions for Use, Medication...: November 29, 2022 Corporation, Danbury CT has been appointed to its of... California, and Instructions for Use, and summarize microbiology studies on new inhaled drug.! Ct. MannKind Corporation employees in Danbury, CT. MannKind Corporation headquartered in Westlake Village, California, Medication. Environment where diversity of background, thought, and summarize microbiology studies on new inhaled drug.! Position for an experienced Microbiologist to join our Inhalation Research Team in,... The primary responsibility will be to plan, execute, and summarize microbiology studies on new drug., at MannKind we depend on a rich blend of ideas experienced to... And summarize microbiology studies on new inhaled mannkind corporation danbury, ct address substances strive to provide work! Join our Inhalation Research Team in Danbury, CT about Management provide a work environment where diversity background.

Wealthy Neighborhoods In Guadalajara, Seller Property Questionnaire Form, Navy Boot Camp Issued Backpack, Evri International Contact, Articles M